H|T: The Healthtech Times – AI takeover: predictive pitfall or “medicine’s biggest moment” since antibiotics?
Plus: Quebec City-based OpSens acquired by US firm in $345M deal.
Plus: Quebec City-based OpSens acquired by US firm in $345M deal.
Pfizer Canada is earmarking $1.4 million in in-kind support and donations as part of the program.
Plus: US mental health startup Headway raises $125 million at $1 billion valuation.
Series A round comes almost exactly one year after rebranding from NERv Technology.
OpSens said acquisition will provide the company with a global sales channel.
Plus: VC interest in fertility continues with $20M Series A for Pollin.
Projects eligible for up to $800,000 over three years.
The projects address a sector facing budgetary strain, high community needs, and a persistent labour shortage.
Medreddie secures funding from The Firehood, Forum Ventures, BDC Capital’s Thrive Lab.
Plus: Thorne HealthTech misled investors around acquisition, suit says.
The raise highlights a recent flurry of rounds in the fertility space.
Toronto-based senior care startup will use funding to begin expansion to US market.
Plus: Digital health, health IT funding slumped in Q2, but some bright spots remain.
Montréal startup’s backers include Theodorus, Eurêka, BKR Capital, Sandpiper, and ACET Capital.
Brian O’Callaghan to lead Toronto firm as founder transitions to chief innovation officer.